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A B S T R A C T
Background: Lithium treatment is associated with an increase in magnetic resonance imaging derived measures
of white matter integrity, but the relationship between the spatial distribution of brain lithium and white matter
integrity is unknown.
Methods: Euthymic patients with bipolar disorder receiving lithium (n=12) and those on other medications but
naïve to lithium (n=17) underwent diffusion imaging alongside matched healthy controls (n=16).
Generalised fractional anisotropy (gFA) within white matter was compared between groups using a standard
space white matter atlas. Lithium-treated patients underwent novel multinuclear lithium magnetic resonance
imaging (7Li-MRI) to determine the relative lithium concentration across the brain. The relationship between
7Li-MRI signal intensity and gFA was investigated at the resolution of the 7Li-MRI sequence in native space.
Results: Lithium-treated bipolar disorder and healthy control groups had higher mean white matter gFA than the
bipolar disorder group treated with other medications (t=2.5, p < 0.05; t=2.7, p < 0.03, respectively). No
differences in gFA were found between patients taking lithium and healthy controls (t=0.02, p=1). These
effects were seen consistently across most regions in the white matter atlas. In the lithium-treated group, a
significant effect of the 7Li-MRI signal in predicting the gFA (p < 0.01) was identified in voxels containing over
50% white matter.
Limitations: Cross-sectional evaluation of a relatively small cohort.
Conclusions: The higher gFA values observed in the lithium-treated bipolar disorder group suggests that long-
term lithium is associated with greater white matter integrity. Our novel analysis supports this further, showing
a positive association between white matter gFA and the spatial distribution of lithium.
1. Introduction
Bipolar disorder is a major mental illness affecting 1% of the world's
population. Although numerous treatments are available, lithium re-
tains a key position in major treatment guidelines, notably for the
prevention of manic episodes (Severus et al., 2014). The mechanisms by
which lithium achieves its effects are not fully understood and we lack
detailed information about its tissue level distribution and how this
relates to its actions in the brain.
Various neuroimaging techniques have been used to identify the
structural and functional changes that occur in the brain during treat-
ment with lithium. In bipolar disorder, cross-sectional structural mag-
netic resonance imaging (MRI) studies have revealed that treatment
with lithium is associated with increased grey matter volume and cor-
tical thickness (Hafeman et al., 2012; Hibar et al., 2018), and long-
itudinal studies have reported progressive increases in measures of grey
matter volume following lithium initiation (Lyoo et al., 2010). These
studies have generally shown that the effects of lithium on MRI esti-
mates of grey matter volume are not uniform across the brain, and may
localise to candidate regions such as the hippocampus, amygdala,
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anterior cingulate and prefrontal cortex (Zung et al., 2016; Hibar et al.,
2018; Hibar et al., 2016; Monkul et al., 2007).
Whilst the effects of lithium on white matter are not fully under-
stood, in bipolar disorder it has been consistently shown to positively
influence measures of white matter integrity. Diffusion MRI (dMRI)
enables the examination of the microstructural properties of tissue by
mapping water molecule diffusion. In pure fluid states, water diffuses
equally in all directions (isotropic). In neurons, water cannot readily
cross the hydrophobic myelin sheaths and diffusion is restricted (ani-
sotropic) along the direction of the axon. The parallel configuration of
axons in white matter renders this directional diffusion detectable at
the microstructural scale, reflected in the dMRI-derived parameter of
fractional anisotropy (FA). Decreases in FA within white matter have
been shown to correspond with demyelination and axonal injury
(Song et al., 2002), such that FA is held to be a measure of white matter
integrity. A number of studies have examined regional FA in bipolar
disorder, generally reporting low FA values in white matter regions and
tracts involved in mood regulation (Adler et al., 2006; Foley et al.,
2018; Bruno et al., 2008; Benedetti et al., 2011). The findings from
whole brain dMRI studies are heterogeneous, but meta-analysis has
identified two significant clusters of low FA in the right hemisphere
(parahippocampal gyrus and the anterior cingulate/subgenual cingu-
late cortex) (Marlinge et al., 2014). White matter FA is greater in pa-
tients with bipolar disorder taking lithium compared to those on other
medications, and the differences may be a function of the duration of
treatment (Macritchie et al., 2009; Gildengers et al., 2015;
Haarman et al., 2016). In a recent region of interest (ROI) study using
longitudinal dMRI data from adolescents with bipolar disorder
(Kafantaris et al., 2017), baseline FA values in the cingulum hippo-
campus were lower than healthy controls and increased following
treatment with lithium, the effect being most marked in responders.
However, in the absence of a whole brain analysis, it remains unclear
whether this effect of lithium is regionally specific or global.
Regionally specific effects of lithium would indicate either that
brain regions are differentially sensitive to its effects or that the drug
itself is heterogeneously distributed across the brain. Recent advances
in multinuclear MRI (7Li-MRI) have permitted the rapid determination
of brain lithium distribution in vivo (Smith et al., 2018) and demon-
strated a heterogeneous distribution of lithium in bipolar disorder, in
keeping with previous rodent imaging and human magnetic resonance
spectroscopy studies (Lee et al., 2012; Zanni et al., 2017). It would
therefore be reasonable to propose that the effects of lithium on white
matter integrity relate to its regional concentration and the combina-
tion of 7Li-MRI and dMRI affords the capability to explore this.
In this study we compared generalised FA (gFA), a measure analo-
gous to FA but better able to account for crossing fibres (Tuch, 2004),
across white matter ROI in patients with bipolar disorder receiving li-
thium, those taking other maintenance medications but naïve to li-
thium, and a healthy comparator group. Patients receiving lithium
additionally underwent an assessment of brain lithium distribution by
7Li-MRI. We hypothesised that gFA values in patients receiving lithium
treatment would exceed those of patients on other treatments and be
comparable to healthy controls, and that the areas of the brain with the
greatest signal intensity on 7Li-MRI would be those with the largest
magnitude gFA in the lithium treated group.
2. Methods
2.1. Subjects and assessments
Twenty-nine euthymic subjects with a diagnosis of bipolar disorder
(I or II) and sixteen healthy control subjects recruited to the Bipolar
Lithium Imaging and Spectroscopy Study (BLISS) were investigated. Of
those with bipolar disorder, twelve were taking lithium as a long-term
treatment (Bipolar Disorder Lithium, BDL) and seventeen were taking
other maintenance treatments but were naïve to lithium (Bipolar
Disorder Control, BDC). The healthy control subjects (HC) had no his-
tory of psychiatric illness and were not taking any psychotropic medi-
cations. Subjects attended a screening visit to confirm eligibility and
underwent a structured clinical interview using the NetSCID diagnostic
tool (a validated online version of the Structured Clinical Interview for
DSM-5 Criteria; Telesage, Inc., Chapel Hill, NC, USA). Interviews and
objective ratings were conducted by a trained clinical research assistant
(CJF) and discussed with a senior psychiatrist (DAC). All subjects were
18–65 years of age and between 50 and 150 Kg in weight (upper limit
determined by MRI scanner bed restrictions). Across all groups, subjects
were excluded if they had a contraindication to magnetic resonance
examination (including claustrophobia), a current or past medical
condition deemed likely to tangibly affect brain structure, a substance
use disorder (current or to a significant degree in the past; NetSCID
Module E), a weekly alcohol intake exceeding 21 units (self-reported), a
learning disability or an impairment of capacity. Patients were excluded
if they were currently liable to detention under the Mental Health Act
1983 (amended 2007). Comorbid psychiatric diagnosis in the patients,
assessed using the NetSCID, was permissible (excluding neurodevelop-
mental, substance use as previously described and neurocognitive dis-
orders) so long as the primary diagnosis was bipolar disorder, con-
firmed by a senior psychiatrist (DAC) reviewing case notes as required.
Euthymic mood state was confirmed at entry to the study, defined as
scores of less than seven on both the 21-item Hamilton Depression
Rating Scale (HAM-D) and the Young Mania Rating Scale (YMRS). BDL
subjects were required to have been taking lithium carbonate (Priadel™
modified release once daily) regularly for at least one year at the time of
recruitment (target therapeutic range 0.6–1.0mmol/L) and all were
taking at least one concomitant medication. BDL subjects completed the
Lithium Side Effects Rating Scale (LISERS), a self-administered scale
rating the common side effects of lithium, each on a four-point severity
scale and expressed as a summated score (Haddad et al., 1999). All
scans were performed at 9 am and the BDL subjects were instructed to
take their lithium as usual the night before and submitted to a blood
test immediately prior to scanning to measure their serum lithium
concentration. All subjects provided written informed consent and the
study was granted a favourable ethical opinion by a United Kingdom
National Research Ethics Committee (14/NE/1135).
Group comparison: Statistical data analysis was performed using
Matlab R2016b (Mathworks® Inc., Natick, MA, USA). Prior to com-
parison of groups, continuous variables were tested for normality of
distribution using the Kolmogorv–Smirnov test and by examining Q–Q
plots. Normally distributed variables were examined using the Student's
t-test, non-parametric data were compared using the Mann–Whitney U
test. Dichotomous data with samples containing less than five per cell
were analysed using a Fisher's exact test, whilst other dichotomous data
were analysed using a χ2 test. All statistical tests were regarded sig-
nificant at p < 0.05.
2.2. Image acquisition
Scanner and coil systems: All magnetic resonance data were acquired
on a Philips 3T Achieva scanner (Philips Medical Systems, Best, The
Netherlands) with 1H structural and diffusion weighted imaging per-
formed using a Philips 8-channel SENSE head coil in all subjects. 7Li-
MRI, together with an additional 1H structural image for the purposes
of registration, was performed using a double tuned 1H/7Li radio-
frequency (RF) birdcage head coil (RAPID Biomedical, Rimpar,
Germany).
T1-weighted imaging acquisition: 3D T1-weighted images (T1w) of
brain anatomy, acquired in all subjects using the 8-channel SENSE head
coil, were obtained with a 1H gradient echo sequence (TR = 9.6ms,
TE = 4.6ms, FOV = 240 × 240 × 180mm3, acquisition ma-
trix = 240 × 208 × 180, acquisition voxel size = 1×1.15 × 1mm3,
reconstructed into a matrix size of 256 × 256 × 180, 1 average). Those
in the BDL group were also scanned using a double tuned 1H/7Li head
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coil, with a 1H gradient echo sequence (TR = 8.2ms, TE = 4.6ms,
FOV = 216 × 240 × 175mm3, acquisition ma-
trix = 180 × 200 × 146, acquisition voxel = 1.2×1.2×1.2 mm3
reconstructed into a matrix size of 240 × 240 × 146, 1 average). The
total acquisition time for each sequence was less than 5 min.
Diffusion-weighted imaging acquisition: dMRI data was acquired using
a single-shot pulsed gradient spin echo (EPI) sequence
(TR=10,200ms, TE = 74ms). For each subject, 64 b1000 diffusion-
weighted volumes were collected along non-collinear directions. In
addition, one b0 volume was also acquired. Each volume consisted of
55 transverse slices (FOV = 240 × 240 × 137.5 mm3, voxel
size = 2.5 mm isotropic, no gap). The total acquisition time for this
sequence was less than 13 min.
7Li magnetic resonance imaging: 7Li 3D Balanced Steady State Free
Precession (bSSFP) gradient echo acquisition (7Li-MRI) was acquired in
eleven of the BDL subjects using a protocol constructed for maximal 7Li
signal amplitude (FOV = 480 × 480 × 175mm3, 20 × 19 × 7 ac-
quisition matrix and 24.0× 25.3× 25.0mm3 voxel size, with
TR = 9.4ms, TE = 4.5ms, flip angle = 60°, receiver
bandwidth = 219Hz/pixel, 500 averages per dynamic, 3 dynamics).
Data were reconstructed into a 32 × 32 × 7 matrix with a voxel size of
15 × 15 × 25mm3. The sequence, lasting approximately eight min-
utes, was conducted thrice without a notable interval and the three scan
dynamics were averaged in complex form.
2.3. Image processing and analysis
All T1w, dMRI and 7Li-MRI images were exported in DICOM format
and converted to NIFTI format data using the Matlab toolbox ‘DICOM to
NIfTI’ (Xiangrui, 2017). Data pre-processing and analysis were per-
formed using Nipype, a Python based platform that provides a uniform
interface to existing neuroimaging software and facilitates interaction
between these packages within a single workflow (Gorgolewski et al.,
2011). An outline of the processing pipeline is shown in Fig. 1.
T1w image processing: T1w structural images acquired during the 1H
imaging session were registered to the standard Montreal Neurological
Institute (MNI) 2mm brain using the Functional MRI of the Brain
(FMRIB) Linear and Non Linear Image Registration Tools
(Jenkinson et al., 2012). These images were also linearly co-registered
to the T1w structural image acquired during the 7Li imaging session
using FMRIB's Linear Image Registration Tool (Jenkinson et al., 2012).
T1w structural images acquired during the 7Li imaging session were
segmented into three tissue classes (grey matter, white matter and
cerebrospinal fluid) using the FMRIB Automated Segmentation Tool
(Zhang et al., 2001).
Diffusion-weighted image processing: dMRI images from every subject
were corrected for motion and eddy-current distortions using the eddy
correct and bvec rotation utility in the FMRIB Software Library (FSL)
(Andersson and Sotiropoulos, 2016). The b0 image was used as the
reference image for realignment of all the dMRI images, and mean
displacement for each subject across the acquisition was calculated.
One-way ANOVA failed to reveal a significant difference between the
mean displacement between the three groups (p=0.64). Subsequently,
skull-stripping was performed on the b0 image using FSL's Brain Ex-
traction Tool (Smith et al., 2002) and images were visually inspected to
ensure skull-stripping had occurred successfully. A Constant Solid Angle
(Q-Ball) model with fourth-order spherical harmonics was fitted to
motion-corrected dMRI images using the Python package Dipy (version
0.11) (Garyfallidis et al., 2014) yielding an estimation of gFA for each
brain voxel. gFA was chosen in favour of FA owing to the ability of the
Q-Ball model to account for crossing fibres (Tuch, 2004). gFA maps
were co-registered with T1w structural images using FMRIB's Linear
Image Registration Tool (Jenkinson et al., 2012) with six degrees of
freedom. gFA maps were transformed into MNI space by applying the
transformation matrix obtained from registering the structural T1w
images to the standard MNI 2mm brain using FMRIB's Non Linear
Image Registration Tool (Andersson et al., 2007).
For the analysis of mean gFA across the white matter for each
subject in MNI space, the mean gFA across all voxels in the John
Hopkins University (JHU) White-Matter Tractography ROI atlas
(Wakana et al., 2004) was calculated. To quantify differences across
groups (BDC, BDL, and HC), the effects of age and sex were regressed
out and the residuals were compared between the groups. One-way
ANOVA was used to test for group differences in mean white matter
gFA residuals, followed by post-hoc t-tests (applying Tukey's correction
for multiple comparisons) to determine the direction of effect. The
statistical significance threshold was set at p < 0.05. Fig. 1A shows a
schematic outline of this processing step.
For the ROI based analysis of gFA in MNI space, region-wise dif-
ferences in mean gFA were determined for each JHU ROI by computing
Fig. 1. Schematic outline of processing
pipeline. (A) gFA ROI analysis between
groups was performed by transforming
the gFA maps into standard space and
applying the John Hopkins University
(JHU) atlas. (B) The gFA ∼ lithium
analysis for each subject was performed
in native space at the resolution of the
lithium image. The T1w image was
used to identify lithium voxels con-
taining a certain percentage of white
matter, which essentially creates a
mask. The mask was applied to both
the gFA map and the 7Li-MRI image.
Finally, mean gFA in each mask voxel
was plotted against the 7Li signal.
Hence, each data point corresponds to
a lithium voxel in a subject.
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effect sizes (Cohen's d) between the BDL and BDC groups. Effect sizes
were computed using residuals after regressing out the effects of age
and sex for each individual ROI. Estimating the statistical significance
of ROI-specific changes was avoided because of the small sample sizes,
with the measured effect sizes serving to demonstrate spatial hetero-
geneity of the effects between groups. In other words, this analysis did
not seek to determine whether any ROIs differed significantly in gFA
between groups, but more cautiously explored whether there was spa-
tial heterogeneity in the effects between groups.
7Li-MRI image processing: 7Li-MRI image analysis was performed in
native space due to the relatively low spatial resolution of these images
(voxel size 24.0× 25.3× 25.0mm3). After segmentation of the T1w
structural image in subject native space, percentage tissue content (grey
matter, white matter and cerebrospinal fluid) was estimated for each
7Li-MRI voxel. gFA maps were linearly registered to the same subject
space and the relationship between mean gFA and lithium signal within
each 7Li-MRI voxel was investigated at white matter thresholds ranging
from 0 to 100% in steps of 25%. In essence, we performed all analyses
steps at the resolution of the lithium images in subject space. This en-
sured that no effect of up-sampling, or interpolation of low resolution
images, would affect our results. Fig. 1B shows a schematic outline of
this processing step.
To enable a group analysis of the association between gFA and 7Li-
MRI signal intensity, a linear mixed effects model was used to account
for inter-subject variations (Winter, 2013). As fixed effects, we entered
gFA, age and sex (without interaction term) into the model. As random
effects, we had intercepts for subjects and by-subject random slopes for
the effect of 7Li-MRI signal. Visual inspection of residual plots did not
reveal any obvious deviations from homoscedasticity or normality. P
values were obtained by likelihood ratio tests of the full model with the
fixed effect of 7Li-MRI signal against the model without the fixed effect
of 7Li-MRI signal assuming a significance threshold of p < 0.05. Sup-
plementary Information A shows the full linear mixed effect analysis
and additional tests to determine the random effects.
Supplementary analysis: The results presented in the body of the
manuscript are derived from the gFA analysis. To facilitate comparison
of our data with other studies in bipolar disorder, a standard Fractional
Anisotropy analysis was also performed (including the determination of
the spatial relationship with 7Li-MRI signal intensity). The analysis pi-
peline was identical to that described for gFA, except that the FSL ‘dtifit’
function was used to generate the FA maps. The process and results of
this analysis are provided in Supplementary Information B, qualita-
tively matching the gFA findings below, with only minor differences in
effect size.
3. Results
3.1. Group characteristics
Twelve BDL subjects (five women; mean age: 46 ± 13 SD years),
seventeen BDC subjects (eleven women; mean age: 44 ± 12 SD years)
and sixteen HC subjects (ten women; mean age: 49 ± 3 SD years) were
included in the analysis. One BDL subject was excluded from the 7Li-
MRI analysis because their lithium imaging data was acquired during
the 7Li-MRI sequence development phase and the acquisition protocol
was inconsistent with the other subjects in the study. The groups did
not differ in mean age (F=0.6; p=0.77) or sex distribution (χ2 = 1.8;
p=0.45) but there was a difference in duration of education (F=5.3;
p=0.01) (Table 1). Post-hoc testing revealed that the HC group re-
mained in education for longer than the BDL group (t=2.59; p=0.03)
and the BDC group (t=2.95; p=0.01), but the bipolar disorder groups
did not differ in years of education (t=0.12; p=0.9). Regarding ill-
ness characteristics, the BDL and BDC groups did not differ in duration
of illness (Mann–Whitney U=79.0; p=0.66), subtype (BD I versus II,
Fisher's exact test p=0.11), history of psychosis (χ2 = 0.36; p=0.55)
or presence of co-morbid psychiatric diagnosis (Fisher's exact test
p=0.42). The groups differed in HAM-D scores (F=3.97; p=0.03),
the HC group having lower scores than the BDC group (t=2.65;
p=0.03) but not the BDL group (t=2.09; p=0.10); the BDL and BDC
groups did not differ in depression rating scores (t =−0.33; p=0.94)
and all were euthymic.
All subjects with bipolar disorder were taking some form of medi-
cation at time of scanning. Fisher's exact tests were performed in order
to compare the use of medication by class between diagnostic groups.
Barring lithium, no significant differences were found between the bi-
polar disorder groups across all major medication classes. Medication
usage information for each group and their corresponding p values are
provided in Table 2.
3.2. Mean white matter gFA comparison between groups
A significant negative correlation (r=−0.52; p=0.0002) between
mean white matter gFA and age was found across all subjects. This was
anticipated as FA has previously been shown to be negatively associated
with age in adulthood (Lebel et al., 2010). After regressing out the ef-
fects of age and sex, ANOVA revealed a significant difference between
the groups (F=4.05; p=0.02; Fig. 2B) and post hoc tests revealed that
the BDL and HC groups exhibited higher mean white matter gFA re-
siduals compared to the BDC group (BDL vs BDC, t=2.5; p=0.05)(HC
vs BDC, t=2.7; p=0.03). No differences were found between the BDL
and HC groups (t=0.02 p=1).
3.3. Region of interest gFA group comparison
Region-wise gFA effect sizes for the comparison BDL > BDC are
shown in Fig. 3. Subjects taking lithium exhibited higher gFA in 44 out
of 48 ROIs compared to those taking other medications for bipolar
disorder but naïve to lithium, with eight regions exhibiting an effect
size of greater than 0.8 (signifying a large effect). Effect sizes ranged
from−0.3 to +1.5, indicating spatial heterogeneity in gFA differences
between the groups. No significant difference was observed in the
magnitude of the effects sizes when comparing the ROIs in the right and
left hemispheres (p=0.19 in a rank-sum test). All ROI labels and their
corresponding effect sizes are provided in Supplementary Information
A.
3.4. Co-localisation of lithium and gFA
The relationship between white matter integrity and the spatial
distribution of lithium was determined in a linear mixed effect analysis
of 7Li-MRI signal intensity and gFA values in voxels containing varying
proportions of white matter at the resolution of the 7Li-MRI scan
(Fig. 4). Results revealed a highly significant association between the
7Li-MRI signal and gFA (p < 0.01) once white matter content exceeded
50% in the 7Li-MRI voxel of interest.
Linear mixed effect modelling was used to test a random slope
model against a random intercept model to determine whether there
was evidence to suggest that individual subjects need to be modelled
with individual slopes. These results revealed there was a significant
difference in the models accounting for a subject specific slope versus
one that does not (p < 0.05). The full linear mixed effect analysis is
described in detail in Supplementary Information A.
4. Discussion
In this study, we report that patients with bipolar disorder treated
with lithium have white matter gFA values comparable to healthy
controls and greater than bipolar disorder patients receiving other
medications. Further, as hypothesised, the spatial distribution of the
7Li-MRI signal positively correlated with gFA in those prescribed li-
thium.
There is a growing literature suggesting that in bipolar disorder,
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lithium treatment positively influences white matter integrity, as de-
termined using diffusion MRI techniques (Hafeman et al., 2012;
Kafantaris et al., 2017). We sought to determine whether there was a
spatial association between gFA and the distribution of lithium in the
brain, given our recent observation of greater 7Li-MRI signal intensity
in white matter compared to grey matter (Smith et al., 2018). Whilst
dMRI techniques are well established, our combined analysis of gFA
and 7Li-MRI data was novel and so exploratory in nature. A major
challenge in this analysis was that the lithium images were relatively
low resolution compared to the T1w and dMRI images, meaning that a
single 7Li-MRI voxel often contained mixed tissue types. To enable a fair
comparison, all analyses using the 7Li-MRI data were performed in
native space at the resolution of the lithium image. Results from our
linear mixed effect model show the emergence of a robust and highly
significant effect of the 7Li-MRI signal in explaining gFA in 7Li-MRI
image voxels comprised of 50% white matter or more. Further, we
found a significant difference between the random intercept model and
the random slope model, potentially suggesting subject-specific slopes
of the gFA ∼ lithium relationship. However, these results attained
statistical power through the use of linear mixed effect modelling by
estimating associations on the BDL group as a whole. Our data did not
permit us to derive reliable subject specific slopes. Hence, at the present
stage, we cannot conclude the significance of individual slopes, nor can
we infer the causality of the association between gFA and lithium.
However, future work with a larger sample will determine whether
individual subject-specific slopes are a robust finding and if so, explore
their relationship to serum lithium concentrations and clinical indices
such as response to lithium, side-effect profiles and cognitive function.
Lithium is purported to exert a range of neurorestorative effects,
many of which could influence white matter microstructure and affect
Table 1
Subject characteristics.
Bipolar disorder Lithium (n=12) Bipolar disorder control (n=17) Healthy Control (n=16) Significance
Sex (M/F) 7/5 6/11 6/10 p=0.45
Age (years) 46(13) 44(12) 49(3) p=0.77
Educational level (years) 14(2) 14(2) 17(3) p=0.87
YMRS score 1(1) 1(1) 0.2(0.5) p=0.96
HAM-D score 5(6) 5(5) 1(1) p=0.03
Bipolar disorder subtype (I/II) 6/6 3/14 n/a p=0.11
History of psychosis (present/absent) 5/7 9/8 n/a p=0.55
Secondary diagnosis present 58% 76% n/a p=0.42
Duration of illness (years) 9.5(9.9) 10.46(8.9) n/a p=0.66
Duration of lithium treatment (years) 8(9) n/a n/a n/a
Priadel™ dose (mg) 900(130) n/a n/a n/a
Serum lithium concentration (mmol/L) 0.8(0.13) n/a n/a n/a
LISERS score 17(13) n/a n/a n/a
YMRS: Young Mania Rating Scale. HAM-D: Hamilton Rating Scale for Depression. LISERS: Lithium Side Effects Rating Scale. Values reported as mean (standard
deviation).
Table 2
Medication use by class. Fisher's exact tests found no differences in medication class between diagnostic groups other than lithium (OR: adds ratio).
Medication class Bipolar disorder lithium (n=12) Bipolar disorder controls (n=17) Significance
Antipsychotics 8 (66%) 11 (65%) OR = 1.1, p=1
Antidepressants 6 (50%) 10 (59%) OR = 0.7, p=0.7
Anticonvulsants 5 (42%) 10 (59%) OR = 0.5, p=0.5
Anxiolytics 3 (25%) 4 (24%) OR = 1.1, p=1
Hypnotic 3 (25%) 2 (12%) OR = 2.5, p=0.6
Antihistamine 0 1 (6%) OR = 0, p=1
Over the counter 0 1 (6%) OR = 0, p=1
Mood stabilisers/mania 12 (lithium, 100%) 0 n/a
Fig. 2. gFA group comparison. (A) Association between mean white matter gFA and age. Each dot is an individual subject and lines indicate the least squared
regressions. (B) Group comparison of mean gFA residuals after correction for age and sex.
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gFA. For instance, lithium is known to inhibit glycogen synthase kinase
3β and inhibition of this enzyme increases the number of oligoden-
drocytes and promotes peripheral nerve myelination in mice
(Makoukji et al., 2012; Azim and Butt, 2011). Lithium treatment has
been shown to be positively associated with MRI measures of white
matter integrity (Gildengers et al., 2015; Haarman et al., 2016;
Macritchie et al., 2009) as well as protect against a decrease in white
matter volume over time (Berk et al., 2017). Lithium was associated
with an increase in FA in the cingulum hippocampus in a recent long-
itudinal study of adolescents with bipolar disorder, where responders to
treatment showed the greatest percentage increase in FA
(Kafantaris et al., 2017). However, the lack of a treatment comparator
group limits the extent to which the FA change can be specifically at-
tributed to lithium.
Lithium-related alterations in water homeostasis also require
consideration in the interpretation of its effects on dMRI-derived mea-
sures. Rats fed lithium for five weeks have been shown to have greater
brain tissue water content compared to placebo controls (Phatak et al.,
2006) and it has been argued that this may underpin the volumetric
changes detected in neuroimaging studies in bipolar disorder
(Regenold, 2008). However, the differences in water content reached
significance in the frontal cortex only, suggesting regional specificity of
action but detracting from the explanation that water content change
accounts for the more widespread cortical differences in grey matter
volume on MRI. Increased water content driven by lithium cannot ea-
sily explain its effects on FA either, as widespread increases in free
water content within white matter has been linked to decreased FA, at
least in first-episode patients with psychosis (Lyall et al., 2018). Notably
in the current study, the bipolar groups did not differ in the presence or
absence of a history of psychosis during mania or depression.
Fig. 3. Region-wise gFA effect sizes (Cohen's d) per JHU ROI comparing BDL > BDC. Top: JHU ROIs in standard space are colour coded according to the effect size of
BDL > BDC. Bottom: Bar plot showing individual effect sizes for each ROI. Full ROI labels and all effect sizes are provided in Supplementary A. Note effect sizes are
calculated on residual gFA values after age and sex correction for each ROI. (For interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
Fig. 4. Relationship between lithium signal amplitude and gFA. Relationship between 7Li-MRI signal intensity and mean gFA in 7Li-MRI voxels containing varying
levels of white matter (ranging from 0 to 100% in steps of 25%). Colours represent individual subject data points and dashed lines represent individual subject least-
squares regression line. The black line represents the group linear mixed effects regression line. p values represent significance of a theoretical likelihood test
comparing linear mixed effect models which do and do not include 7Li signal as a fixed effect. (For interpretation of the reference to colour in this figure legend, the
reader is referred to the web version of this article.)
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In practice, lithium may be preferentially prescribed to those
deemed more likely to respond to it, to those with more severe pre-
sentations or when there is confidence that the patient will manage
regular blood level monitoring. It could be argued that the differences
in FA between patients treated with lithium and those on other medi-
cations reflects these, or other as yet unidentified illness characteristics
driving a selection bias rather than a direct action of lithium. For in-
stance, patients with more severe illnesses (BD I) are known to have
lower white matter FA values compared to those with milder pre-
sentations (BD II) (Foley et al., 2018). If our lithium treated group were
composed mostly of patients with a mild illness form, illness severity
rather than the effects of lithium might account for our gFA findings.
We found no significant difference in the distribution of disorder sub-
types in or bipolar groups. Numerically but not significantly, BD I
outweighed BD II in the lithium treated group – one might therefore
have expected the FA values in the BDL group to be lower on the basis
of illness severity but they did not differ from the healthy controls. Our
finding of a relationship between gFA and regional lithium concentra-
tion strengthens the argument that lithium directly influences white
matter integrity.
Future work: In future work, multimodal imaging studies utilising
7Li-MRI and larger cohorts that permit the segregation of subjects into
groups based upon lithium response may reveal localised response-
specific relationships between regional brain lithium concentration and
MRI derived measures such as gFA. Randomised controlled longitudinal
studies would be required to properly assess the relationship between
lithium treatment, gFA change and response, and such investigations
would be strengthened by inclusion of 7Li-MRI examination.
Ultimately, such approaches may help characterise lithium responders
and move us a step closer to personalised medicine in bipolar disorder.
The development of multimodal 7Li-MRI analysis techniques affords the
opportunity to better investigate the effect of lithium in vivo, and we
can envisage studies that may advance our understanding of the mode
of action of this important mood stabilising drug. The combination of
7Li-MRI and proton magnetic resonance spectroscopic imaging (1H-
MRSI), for instance, could be used to explore the dose-related effects of
lithium on the neurometabolites implicated in its actions. The com-
parable resolution of 7Li-MRI and 1H-MRSI lends itself to this combi-
nation.
Limitations: Given the exploratory nature of our analysis using a
relatively small cohort of patients, our results should be interpreted
with caution. Whilst we found a significantly greater mean white
matter gFA in long-term lithium-treated patients relative to lithium
naïve patients, we cannot infer regional specificity. The detection of
statistically significant region-specific changes requires larger cohorts
factoring in corrections for multiple comparisons or synthesis by meta-
analysis (Wise et al., 2016; Pezzoli et al., 2018). Further, the analysis
exploring the relationship between gFA and 7Li-MRI signal intensity
was conducted in native space and as a result, we are not able to
comment on the anatomical location of voxels by white matter quartile
for the group. In our cross sectional study, we recruited patients for
whom lithium had been considered clinically by their treating team and
our groups comprised a mixture of bipolar disorder type I and II. Whilst
the subtype proportion did not differ between the groups, future studies
may benefit from the investigation of purer samples.
In conclusion, we report dMRI results that are consistent with the
previous literature and a novel observation of the correlation between
gFA and regional brain lithium concentration. 7Li-MRI is a new tech-
nique that holds potential to provide multiple insights into the effects of
lithium in the brain in bipolar disorder. However, the limited spatial
resolution of this technique restricted the present study to reporting
results based on voxels containing mixed tissue types. Despite this, we
found a consistent significant relationship between 7Li-MRI signal and
gFA in voxels containing 50% white matter or more. Whilst challen-
ging, there is scope for on-going technical development of 7Li-MRI with
clear potential to improve the spatial resolution of lithium images. The
ability to co-localise a psychotropic medication with its effect in vivo
spurs us to meet these challenges.
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